Skip to content

Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study

Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06150482
Enrollment
600
Registered
2023-11-29
Start date
2022-09-01
Completion date
2027-12-31
Last updated
2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis

Brief summary

Multicenter, retrospective cohort study investigating healthcare utilization in compensated and decompensated liver cirrhosis patients, including disease course and characteristics associated with healthcare utilization and, for example psychosocial factors.

Interventions

OTHERNo intervention

No intervention

Sponsors

Gelre Hospitals
CollaboratorOTHER
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 18 years of age * Liver cirrhosis, based on biopsy, fibroscan or diagnostic imaging data

Exclusion criteria

* Known malignancy with hepatic metastasis at baseline * Liver transplantation at baseline

Design outcomes

Primary

MeasureTime frame
Number of liver cirrhosis related esophagogastroscopies before liver cirrhosis complications2 years before complication, death or loss to follow-up
Number of liver cirrhosis related outpatient contacts before liver cirrhosis complications2 years before complication, death or loss to follow-up
Number of liver cirrhosis related radiographic imaging before liver cirrhosis complications2 years before complication, death or loss to follow-up
Number of liver cirrhosis related elastographies before liver cirrhosis complications2 years before complication, death or loss to follow-up

Countries

Netherlands

Contacts

Primary ContactB. van Ruijven, MD
britt.vanruijven@maastrichtuniversity.nl+31631239360

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026